Top 50 Biotech VC Funds & Investors in Ireland (August 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Enterprise Ireland
VC Fund
|
36 | Ireland, United States, United Kingdom | Seed, Series A | Software, Information Technology, Health Care | $494k–$12M |
|
SOSV
VC Fund
|
19 | United States, India, United Kingdom | Seed, Convertible Note, Pre-Seed | Biotechnology, Health Care, Software | |
|
Western Development Commission
VC Fund
|
14 | Ireland, United States | Seed, Venture - Series Unknown | Health Care, Medical Device, Biotechnology | $702k–$17M |
|
Irrus Investments
VC Fund
|
8 | Ireland, Sweden, United States | Seed, Venture - Series Unknown | Health Care, Medical Device, Biotechnology | $713k–$24M |
|
Kernel Capital
VC Fund
|
8 | Ireland, United Kingdom, France | Seed, Series A | Software, Information Technology, Health Care | $531k–$9M |
|
Atlantic Bridge
VC Fund
|
7 | United States, Ireland, United Kingdom | Series A, Series B | Software, Information Technology, Artificial Intelligence | $4.5M–$62M |
|
Fountain Healthcare Partners
VC Fund
|
6 | Ireland, United States, France | Series A, Series B, Series C | Health Care, Biotechnology, Medical | $3.3M–$110M |
|
Seroba Life Sciences
VC Fund
|
6 | Ireland, United States, United Kingdom | Series A, Series B | Health Care, Biotechnology, Medical | $4.6M–$105M |
|
Elkstone Capital Partners
VC Fund
|
5 | Ireland, United Kingdom, United States | Seed, Series A | Software, Artificial Intelligence, Health Care | $797k–$18M |
|
AIB Seed Capital Fund
VC Fund
|
5 | Ireland, United States, Jersey | Seed, Series A | Software, Health Care, Medical | $549k–$8.1M |
|
Faber
VC Fund
|
5 | Portugal, United States, United Kingdom | Seed, Pre-Seed, Series A | Artificial Intelligence, Software, SaaS | $29k–$25M |
|
European Investment Bank
VC Fund
|
5 | France, Germany, The Netherlands | Debt Financing, Post-IPO Debt | Biotechnology, Health Care, Energy | $16M–$726M |
|
HBAN
VC Fund
|
4 | Ireland, United Kingdom, United States | Seed, Series A | Software, Health Care, Medical Device | $623k–$9.2M |
|
Atlantic Bridge University Fund
VC Fund
|
4 | Ireland, United States | Seed, Series A, Series B | Health Care, Medical Device, Big Data | $823k–$80M |
|
HBAN Medtech Syndicate
VC Fund
|
4 | Ireland | Seed, Series B | Medical Device, Medical, Health Care | $1.3M–$11M |
|
Boole Investment Syndicate
VC Fund
|
4 | Ireland, Estonia, United States | Seed, Series A | Biotechnology, SaaS, Software | $623k–$2.2M |
|
Furthr VC
VC Fund
|
3 | Ireland | Seed, Venture - Series Unknown | Software, Medical Device, Medical | $753k–$17M |
|
The Yield Lab Europe
VC Fund
|
3 | Ireland, France, United Kingdom | Seed, Series A, Venture - Series Unknown | AgTech, Agriculture, Biotechnology | $1M–$10M |
|
Act Venture Capital
VC Fund
|
3 | Ireland, United States, United Kingdom | Seed, Series A | Software, Information Technology, Artificial Intelligence | $823k–$13M |
|
SciFounders
VC Fund
|
3 | United States, Ireland, United Kingdom | Seed, Pre-Seed, Series A | Health Care, Biotechnology, Medical | $400k–$21M |
|
LSP Dementia Fund
VC Fund
|
2 | Belgium, Ireland, United States | Series A, Series B, Post-IPO Equity | Biotechnology, Health Care, Life Science | $39M–$39M |
|
SVG Ventures
VC Fund
|
2 | Canada, United States, Australia | Non-Equity Assistance, Seed, Pre-Seed | AgTech, Agriculture, Farming | $50k–$4.7M |
|
Ascentifi
VC Fund
|
2 | Ireland | Seed, Series A, Venture - Series Unknown | Health Care, Medical Device, Medical | $2.3M–$34M |
|
Artis Ventures
VC Fund
|
2 | United States, United Kingdom, India | Series A, Series B, Seed | Health Care, Biotechnology, Software | $2M–$127M |
|
Enterprise Equity
VC Fund
|
2 | Ireland, United States, United Kingdom | Seed, Series B | Software, Information Technology, Health Care | $549k–$7.5M |
|
Infinity Capital
VC Fund
|
2 | United States, Ireland, Canada | Series B, Series D | Semiconductor, E-Commerce, Electronics | |
|
DeepIE Ventures Management Co.
VC Fund
|
2 | Ireland, France, Switzerland | Seed, Series A | Manufacturing, AgTech, Software | $648k–$5.5M |
|
Pareto Holdings
VC Fund
|
2 | United States, France, United Kingdom | Seed, Pre-Seed, Series A | Software, Artificial Intelligence, FinTech | $125k–$35M |
|
Gaingels
VC Fund
|
2 | United States, Canada, Mexico | Seed, Series A, Series B | Software, Health Care, Artificial Intelligence | $1M–$100M |
|
Lynett Capital
VC Fund
|
2 | United States, Kenya, Nigeria | Seed, Series A, Pre-Seed | FinTech, Software, SaaS | $120k–$49M |
|
Lightstone Ventures
VC Fund
|
2 | United States, Ireland, India | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics | $7M–$105M |
|
HealthCap
VC Fund
|
2 | United States, Sweden, France | Series B, Series A | Biotechnology, Health Care, Medical | $5.7M–$92M |
|
ARCH Venture Partners
VC Fund
|
2 | United States, China, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics | $10M–$250M |
|
Sol Global investments
VC Fund
|
1 | United States, Canada, Ireland | Corporate Round, Series A, Series B | Health Care, Cannabis, Cloud Computing | |
|
Medicxi
VC Fund
|
1 | United States, United Kingdom, The Netherlands | Series A, Series B, Seed | Biotechnology, Health Care, Pharmaceutical | |
|
Inventages Venture Capital Investment Inc.
VC Fund
|
1 | United States, United Kingdom, Canada | Series A, Series B | Biotechnology, Health Care, Therapeutics | |
|
MML Capital Partners
VC Fund
|
1 | United Kingdom, France, United States | Private Equity, Series A | Manufacturing, Packaging Services, Information Technology | |
|
Google Ventures
VC Fund
|
1 | United States, United Kingdom, Switzerland | Series A, Series B, Seed | Software, Health Care, Biotechnology | |
|
KBI Biopharma
VC Fund
|
1 | United States, Ireland | Seed, Series A, Series D | Biotechnology, Life Science, Medical | |
|
Sanara MedTech
VC Fund
|
1 | Ireland | Corporate Round | Medical, Biotechnology, Medical Device | |
|
Earlybird Venture Capital
VC Fund
|
1 | Germany, United States, United Kingdom | Series A, Seed, Series B | Software, Information Technology, Health Care | |
|
Carragh Holdings
VC Fund
|
1 | Ireland | Series A | Biotechnology, Bioinformatics | |
|
Blue Wire Capital
VC Fund
|
1 | United Kingdom, United States, France | Seed, Pre-Seed, Series A | Software, SaaS, FinTech | $550k–$36M |
|
EarlyBirdCapital
VC Fund
|
1 | Ireland | Seed | Medical, Health Care, Biotechnology | |
|
Ascent Capital
VC Fund
|
1 | India, United States, Ireland | Series C, Series B | Financial Services, Banking, Health Care | $2.5M–$50M |
|
Covidien
VC Fund
|
1 | Ireland, United States | Series A, Series C | Health Care, Biotechnology, Medical Device | |
|
Street Capital
VC Fund
|
1 | Ireland, United States | Seed | Medical, Automotive, Biotechnology | |
|
Wellcome Trust
VC Fund
|
1 | United States, United Kingdom, France | Grant, Series C | Biotechnology, Health Care, Medical | $1.3M–$127M |
|
Cultivian Sandbox Ventures
VC Fund
|
1 | United States, Canada, Germany | Series A, Series B, Series C | Biotechnology, Agriculture, Farming | $2M–$80M |
|
The Foundry
VC Fund
|
1 | Ireland | Series A | Health Care, Therapeutics, Biotechnology | |
| Access all 257 VC funds in Ireland Biotech startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Enterprise Ireland is the government agency responsible for the development and funding of the indigenous business sector. Their mission is to accelerate the development of companies to achieve strong positions in global markets resulting in increased national and regional prosperity. It was founded in 1998 and headquartered in Dublin, Ireland.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Series A
- Geography: Ireland, United States, United Kingdom
Investor stats
- Total investments: 665
- Round size: Seed $494k–$3.3M; Series A $2.2M–$12M
- Lead/follow: 31% lead, 69% follow
- Last fund: May invest from a new fund soon — raised $1.1M in 2021
Portfolio highlights
- mAdme — mAdme Technologies is a digital communications channel that delivers rich and dynamic messages directly to mobile subscribers, with the highest engagement rates.
- Finovation Limited — Finovation Limited
- Touchtech Payments — At Touchtech Payments, believe in making industry changing and innovative technology.
SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Convertible Note, Pre-Seed
- Geography: United States, India, United Kingdom
Investor stats
- Total investments: 1482
- Lead/follow: no public data
Portfolio highlights
- MixRift — MIXRIFT - game developers specialized in Mixed Reality
- unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
- Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.
Supporting communities to grow, investing in businesses to scale and planning for the future of the western region.
Show more...Investment focus
- Industry: Health Care, Medical Device, Biotechnology
- Stage:Seed, Venture - Series Unknown
- Geography: Ireland, United States
Investor stats
- Total investments: 45
- Round size: Seed $702k–$3.9M; Venture - Series Unknown $753k–$17M
- Lead/follow: 18% lead, 82% follow
Portfolio highlights
- Ovagen — Ovagen is a biotechnology company that has developed the process of producing germ free (GF) chicken eggs and GF birds in commercial quantities for use primarily in the pharmaceutical industry. Ovagen can also provide a Contract Research Service and has extensive expertise in SPF poultry & rodent housing & husbandry, in specific poultry& rodent research technologies to GMP standards and in avian transgenics.
- Peroptyx — Peroptyx is a platform that provides managed solutions for machine learning. At Peroptyx, they have assembled and pre-screened a qualified network of data evaluators across the globe. They strategically match ideal evaluators with each product to ensure authentic experiences through consistency and appropriate real-world contexts.
- Galway Biomedical — Galway Biomedical partners with global medical device companies to bring complex braided devices from early concept through to full-scale production.
Irrus Investments is the leading Irish business angel network with international connections. Fueling Irish innovation in medical devices, software, hardware, digital healthcare and life sciences.
Show more...Investment focus
- Industry: Health Care, Medical Device, Biotechnology
- Stage:Seed, Venture - Series Unknown
- Geography: Ireland, Sweden, United States
Investor stats
- Total investments: 34
- Round size: Seed $713k–$4.7M; Venture - Series Unknown $1.2M–$24M
- Lead/follow: 18% lead, 82% follow
Portfolio highlights
- Novus Diagnostics — Sepsis causing pathogen diagnostics under 15 minutes
- Vertigenius — Enhance patient care and treatment options for vertigo and dizziness with Vertigenius, enabling effective management and improved outcomes for your patients.
- Adama Innovations — Sharp Conductive Single Crystal Diamond AFM Probes
Kernel Capital is the independent manager of The Bank of Ireland Kernel Capital Venture Funds, one of the largest and most active sources of equity finance on the island of Ireland. Kernel leverage their extensive network to enable their portfolio companies recruit the highest caliber people, to break into new international markets and to generaterevenues of scale. It is the only investment firm with venture capital Funds dedicated to both jurisdictions on the Island. Kernel have raised over €210M from investors which including their strategic partner Bank of Ireland, Invest NI, Enterprise Ireland, Galway University Foundation, The University of Limerick Foundation, The New York State Common Retirement Fund and undisclosed Family Offices. Consistently delivering strong financial returns for their investors Kernel have led more than 20 substantial trade sales to NASDAQ, NYSE, and LSE listed corporations.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Series A
- Geography: Ireland, United Kingdom, France
Investor stats
- Total investments: 94
- Round size: Seed $531k–$4.4M; Series A $1.4M–$9M
- Lead/follow: 50% lead, 50% follow
- Last fund: May invest from a new fund soon — raised $34M in 2013
Portfolio highlights
- Cirdan — Cirdan provides highly reliable, innovative LIS & imaging solutions for the acceleration & enhancement of diagnosis, optimized for pathology & clinical lab.
- preico — Preico Network empowers Web2 and Web3 developers to create, own, and monetize crypto-native AI models on a decentralized platform
- Pretto — Pretto is the only truly transparent online real estate price comparator.Pretto accompanies you until the signing of your loan, free of charge and without commitment.
Atlantic Bridge is a Growth Equity Firm with a Cross Border Value Add strategy. We invest in deep technology companies in Europe and the US. Our team is made up of successful entrepreneurs and senior technology industry executives and we invest in strong ambitious entrepreneurs and management teams that have the passion and drive to scale up andexploit major growth opportunities. We help our portfolio companies expand and grow internationally through our global platform with our team and offices in London, Dublin, Munich, Paris and Palo Alto.Atlantic Bridge brings together a unique team of technology entrepreneurs, experienced managers, finance professionals, and investment experts. The team contains a wealth of international business experience across Europe, the UK and the US. They have worked together in various capacities for the last 30 years, bringing a true partnership approach to their firm and their investments. Its investors include the founders, leading institutional investors, and private investors with a track record of investment in successful technology companies.Atlantic Bridge has developed a unique and differentiated strategy that focuses on specific technology themes and the implementation of the “Atlantic Bridge Model” for scaling companies internationally. The “Bridge Model” accelerates the scale-up of technology companies in Europe and the US. This approach is highly differentiated and has delivered strong performance results to date.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Series A, Series B
- Geography: United States, Ireland, United Kingdom
Investor stats
- Total investments: 147
- Round size: Series A $4.5M–$26M; Series B $10M–$62M
- Lead/follow: 40% lead, 60% follow
- Last fund: May invest from a new fund soon — raised $88M in 2021
Portfolio highlights
- Aiqudo — Aiqudo offers an artificial intelligence-based technology that connects voice computing to the mobile app ecosystem. Its Voice-to-Action platform lets people use natural voice commands to instantly execute actions in their mobile apps. The company was founded in 2017 and is headquartered in Campbell, California.
- Output Sports — Discover Output's portable and affordable athlete testing and tracking device. Measure strength, power and speed in minutes giving accurate and reliable data.
- Luminate — Luminate Medical is developing LILY, the world's first pain-free and portable solution to prevent hair loss caused by chemotherapy.
Fountain Healthcare Partners is an Irish based life science venture capital fund. Fountain is exclusively focused on the life science sector. Specific areas of interest to them are: specialty pharma, medical devices, biotechnology and diagnostics. They will deploy the majority of their capital in Europe with a strong focus on Ireland.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Series B, Series C
- Geography: Ireland, United States, France
Investor stats
- Total investments: 50
- Round size: Series A $6.3M–$43M; Series B $5.5M–$68M; Series C $3.3M–$110M
- Lead/follow: 42% lead, 58% follow
- Last fund: May invest from a new fund soon — raised $128M in 2019
Portfolio highlights
- Palyon Medical — Palyon Medical Corporation is a medical device company developing technologies for the treatment of chronic pain, spasticity and other neurological diseases.
- Neuromod Devices — Neuromod is the global medical device company that developed Lenire, the FDA Approved tinnitus treatment device.
- Vivasure Medical — Pioneering the Future of Large-Bore Vessel Closure for Arterial and Venous Access. The first and only 100% bio-absorbable, sutureless patch..
Seroba is a leading European life sciences venture capital firm focused on value creation through backing winning innovations in biotech and medtech.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Series B
- Geography: Ireland, United States, United Kingdom
Investor stats
- Total investments: 48
- Round size: Series A $5.4M–$33M; Series B $4.6M–$105M
- Lead/follow: 35% lead, 65% follow
- Last fund: May invest from a new fund soon — raised $111M in 2017
Portfolio highlights
- Coave Therapeutics — Coave Therapeutics is active in the field of gene therapies in rare ocular and CNS (Central Nervous System) diseases.
- Perfuze — Perfuze was founded in 2018 by Wayne Allen and Liam Mullins. Perfuze is located within Galway City in the West of Ireland. The founders have over 30 years combined medtech experience within start-up and large corporations.Perfuze is developing innovative medical technology to treat acute ischemic stroke.Perfuze is developing innovative cathetertechnology to treat acute ischemic stroke. Their technology is intended to provide superior clinical outcomes in shorter procedural times; resulting in safe, cost-effective therapy. Perfuze was founded in 2018 by Wayne Allen and Liam Mullins. The founders have over 30 years combined medtech experience within start-up and large corporations. Perfuze is currently located in the Business Innovation Centre on the campus of the National University of Ireland, Galway, and is in the process of relocating to the IDA Business Park in Dangan, Galway.
- Azafaros — Azafaros aims at developing therapeutic agents for the treatment of rare metabolic disorders such as lysosomal storage disorders through oral administration of azasugar compounds. These novel, very promising agents were discovered by Professor Hans Aerts at Leiden University and Amsterdam UMC and are exclusively licensed to Azafaros.
Elkstone is an investment firm, focusing on entrepreneurs, senior executives, institutional LPs, the venture community, and the Irish diaspora.The objective of the organization is to boost the economic value and overall well-being of the island of Ireland by expanding a network, facilitating deserving investments, and delivering excellentinvestment performance.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Seed, Series A
- Geography: Ireland, United Kingdom, United States
Investor stats
- Total investments: 94
- Round size: Seed $797k–$5M; Series A $5.1M–$18M
- Lead/follow: 47% lead, 53% follow
- Last fund: Likely still investing — raised $110M in 2023
Portfolio highlights
- WrxFlo — WrxFlo deliver real time data insights and software solutions to allow business achieve greater levels of supply chain efficiencies
- Danalto — Simple, cost-effective, high-accuracy Location Services for large open environments, both indoor and outdoor. Asset Tracking made simple!
- Neurobell — NeuroBell develop novel EEG medical devices for early detection and monitoring of neonatal seizures.
The AIB Seed Capital Fund was established in 2007 to provide venture capital for companies at the seed and early stages of development across a range of sectors throughout the Republic of Ireland. The Fund was established under the Enterprise Ireland Seed and Venture Capital Programme 2007-2012.The Fund has a total of €30m under managementwith AIB and Enterprise Ireland both committing €15m. It is managed by experienced managers with extensive expertise in making seed and early stage investments, adding value and facilitating business success.The Fund managers are empowered to make seed investments of up to approximately €500,000. Furthermore, the Fund has the capacity to make investments in later rounds to support the continued growth of investee companies.The Fund will be managed by Enterprise Equity Venture Capital and the Dublin Business Innovation Centre. This unique partnership brings together extensive regional and investment expertise.Enterprise Equity will evaluate and manage all investments outside the city and county of Dublin, as well as investments that require in excess of €250,000 from the fund within the city and county of Dublin.Dublin Business Innovation Centre (DBIC) will evaluate and manage all investments within the city and county of Dublin when the initial investment amount required from the Fund does not exceed €250,000.
Show more...Investment focus
- Industry: Software, Health Care, Medical
- Stage:Seed, Series A
- Geography: Ireland, United States, Jersey
Investor stats
- Total investments: 49
- Round size: Seed $549k–$3.3M; Series A $1.1M–$8.1M
- Lead/follow: 18% lead, 82% follow
Portfolio highlights
- NewsWhip — NewsWhip is the world's most comprehensive content discovery and analytics database. Their suite of products give customers the ability to predict which stories will be important today, and understand how to create successful content over the long term.NewsWhip serves over 500 of the world's leading publishers, brands and agencies,including: Reebok, the Washington Post, Conde Nast, Google, MasterCard, BuzzFeed, Time Inc., and more. NewsWhip Spike is their real-time, predictive content discovery dashboard — offering a one-stop view of what's important across both the web and 5 social networks. Spike is the only tool that discovers stories within 2 minutes of publishing, and predicts their spread across social.NewsWhip Analytics is a database of how audiences have engaged with stories across every social network over the long term. NewsWhip customers use Analytics to benchmark how they stack up against competitors and track engagement trends around events and seasons.
- Offr — Offr is the new way to buy and sell property, quickly and transparently.
- Metabolomic Diagnostics — Metabolomic Diagnostics is a deep-tech company specialized in the development of novel biomarker based diagnostic solutions for complex diseases. The company has developed an effective pipeline to firstly identify diagnostic biomarker panels and then translate these panels into clinical assays ready for application in the clinical laboratory.Thispipeline combines the biomarker multiplexing capabilities of Mass Spectrometry, a powerful analytical technology, with the company’s own informatics and statistics solutions to deliver diagnostic innovation. This is reflected in Metabolomic Diagnostics’ strong and versatile IP portfolio of technical innovations and biomarkers.Our VisionMetabolomic Diagnostics’ primary vision is to develop a portfolio of diagnostic solutions which can determine, early in a woman’s pregnancy,her risk of developing major complications much later in her pregnancy and thus enabling personalized care, adapted to each woman’s individual needs. Pregnancy complications like preeclampsia, gestational diabetes, preterm birth, and in-uterine growth restriction, all have the potential to severely impact on the well-being of mother and child.The company’s innovative diagnostic solutions will assist clinicians in re-imagining how these conditions are managed: our novel risk assessment tools are specifically developed in conjunction with prenatal care providers to ensure they make a difference that really matters. This in turn will enable clinicians to improve pregnancy outcomes globally.Our solutions will empower pregnant women: accurate pregnancy risk information will allow a pregnant woman, in partnership with her care provider, to determine what prenatal care is best for her pregnancy.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Faber is a Lisbon-based venture capital firm investing in outstanding entrepreneurs who innovate at the intersection of science and technology to drive digital transformation and climate action. The firm combines a specialist focus on deep tech early-stage startups with dedicated funds, investment teams and expert advisors to actively helpfounders build global companies powered by AI/Data, Web3 or Ocean/Climate technologies.Faber’s unique approach in Southern Europe is led by an entrepreneurial management partnership and backed by notable thesis-driven institutions and private investors. Investing since 2013, the firm has been an early investor in hard tech companies such as Unbabel, SWORD Health, Codacy, iLoF or YData.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, SaaS
- Stage:Seed, Pre-Seed, Series A
- Geography: Portugal, United States, United Kingdom
Investor stats
- Total investments: 97
- Round size: Seed $549k–$5.2M; Pre-Seed $29k–$3M; Series A $2.5M–$25M
- Lead/follow: 30% lead, 70% follow
- Last fund: Likely actively investing — fund raised in 2024
Portfolio highlights
- Porelio — Porelio is an environmental technology that provides purification technologies for water and industrial chemicals.
- ATMOS Space Cargo — ATMOS Space Cargo develops and manufactures space capsules to return cargo from space, microgravity experiments, Commercial products to entire rocket stages.
- InSpacePropulsion Technologies — Cost-effective, robust, and quickly available propulsion solutions, based on 10+ years of R&D and 40 years of combined experience in space propulsion.
The European Investment Bank (EIB) offers lending, borrowing, and treasury services primarily within the European Union. It provides project loans for public and private sectors, loans to banks and intermediaries, structured finance products, guarantees, and securitization instruments for debts. Additionally, EIB offers equity and fund investmentproducts, including infrastructure and environmental funds, as well as venture capital funds. EIB also supports microfinance and risk-sharing finance for research and innovation, and provides technical expertise for sustainable energy projects. Its services include infrastructure advisory, urban development support, guarantees for transport infrastructure, and funding for public-private partnerships and small- to medium-sized enterprises. The bank serves various sectors, including transportation, energy, health, education, and agriculture.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Energy
- Stage:Debt Financing, Post-IPO Debt
- Geography: France, Germany, The Netherlands
Investor stats
- Total investments: 520
- Round size: Post-IPO Debt $18M–$726M; Debt Financing $16M–$352M
- Lead/follow: 83% lead, 17% follow
Portfolio highlights
- Ukrposhta — Ukrposhta sends and receives shipments from all over the world, as well as orders mail products sent to the most distant corners.
- IPT PowerTech — IPT PowerTech coverage, coupled with our extensive expertise in supply chain management, field implementation, and power systems, has made us one of the most capable companies in handling the most complicated and versatile projects in the MEA region and its neighboring countries.
- Santander Brasil — Banco Santander in Brazil, its largest division in Latin America and one of the world's most important, accounting for 50%.
HBAN is dedicated to raising the profile of business angel investment as an asset class on the island of Ireland and to promote the creation of business angel syndicates.
Show more...Investment focus
- Industry: Software, Health Care, Medical Device
- Stage:Seed, Series A
- Geography: Ireland, United Kingdom, United States
Investor stats
- Total investments: 70
- Round size: Seed $623k–$3.5M; Series A $1.2M–$9.2M
- Lead/follow: 34% lead, 66% follow
- Last fund: May invest from a new fund soon — raised $10M in 2018
Portfolio highlights
- Movetru — Movetru a wearable device that aims to reduce injury and enhance rehabilitation.
- FoodMarble — Your personal breath tester to identify food intolerances and reduce digestive symptoms. Ideal for managing IBS and SIBO, all from the comfort of home.
- Glitch Ads — Launch AI Powered Google Ad Campaigns in Minutes. Think of us like an agency in a box. Built for speed. Priced for scaling companies. Powered by AI.
We invest in entrepreneurs with the ambition to create world-class companies of scale.
Show more...Investment focus
- Industry: Health Care, Medical Device, Big Data
- Stage:Seed, Series A, Series B
- Geography: Ireland, United States
Investor stats
- Total investments: 33
- Round size: Seed $823k–$3.9M; Series A $3.1M–$34M; Series B $16M–$80M
- Lead/follow: 55% lead, 45% follow
Portfolio highlights
- CroíValve — CroíValve is a developed a safe, effective, easy to use, percutaneous solution for treating all patients with severe Tricuspid Regurgitation
- PlasmaBound — PlasmaBound provides a step-change technology, termed Controlled Plasma Ablation (CPA), which facilitates the structural adhesive joining of lightweight materials, namely carbon and glass fibre reinforced composites. CPA technology will accelerate the use of these lightweight composite materials into multi-material structural assemblies, byenabling reliable adhesive joining which is stronger than the composite structures themselves.
- ProVerum Medical — The ProVee stent from Proverum Medical uses 3-D geometry which mirrors and engages with the anatomy of the prostate. The system alleviates Lower Urinary Tract Symptoms (LUTS) by opening the prostatic urethra, applying radial force to the prostatic lobes.
HBAN Medtech Syndicate
Show more...Investment focus
- Industry: Medical Device, Medical, Health Care
- Stage:Seed, Series B
- Geography: Ireland
Investor stats
- Total investments: 13
- Round size: Seed $1.3M–$11M
- Lead/follow: 15% lead, 85% follow
Portfolio highlights
- FeelTect — FeelTect’s technology, Tight Alright, is a pressure sensing, connected-health device for measuring and monitoring sub-bandage pressure during compression therapy, primarily for the millions of people worldwide with venous leg ulcers (VLUs). Compression is a proven therapy for VLUs, however if it’s applied too loose, it’s ineffective, and if it’stoo tight, it’s dangerous.
- Neurobell — NeuroBell develop novel EEG medical devices for early detection and monitoring of neonatal seizures.
- SymPhysis Medical — SymPhysis Medical's goal is to develop innovative technologies that treat a range of chronic diseases, putting the patient experience at the forefront of our design solutions to improve quality of life.About SymPhysis MedicalSymPhysis Medical's emergent technology, releaze, is a drainage technology to treat a common complication oflate-stage cancers, malignant pleural effusion (MPE). MPE causes significant shortness of breath and chest pain in up to 15% of patients with cancer.
Boole Investment Syndicate invests in new technology start-up's with scalability.
Show more...Investment focus
- Industry: Biotechnology, SaaS, Software
- Stage:Seed, Series A
- Geography: Ireland, Estonia, United States
Investor stats
- Total investments: 10
- Round size: Seed $623k–$2.2M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Ovagen — Ovagen is a biotechnology company that has developed the process of producing germ free (GF) chicken eggs and GF birds in commercial quantities for use primarily in the pharmaceutical industry. Ovagen can also provide a Contract Research Service and has extensive expertise in SPF poultry & rodent housing & husbandry, in specific poultry& rodent research technologies to GMP standards and in avian transgenics.
- eID easy — One integration - access a worldwide network of QTSPs & CAs, for eSignatures, eID authentication & eSealing. Ensure full compliance with regulations.
- ArrayPatch — Revolutionising drug delivery with painless microneedle patch technology. Backed by prestigious funding and award-winning innovation.
We are a relationship driven early stage VC investor. We invest in and form close partnerships with the founders we back.We make initial investments at Seed to Series A stage in highly ambitious, born global Irish software and medtech companies. We are hands-on and support teams across key strategic areas to accelerate growth.In addition toproviding institutional investment at an early stage, we reserve significant capital for following on in subsequent rounds. We go the journey with founders.
Show more...Investment focus
- Industry: Software, Medical Device, Medical
- Stage:Seed, Venture - Series Unknown
- Geography: Ireland
Investor stats
- Total investments: 29
- Round size: Seed $878k–$6.3M; Venture - Series Unknown $753k–$17M
- Lead/follow: 34% lead, 66% follow
- Last fund: May invest from a new fund soon — raised $35M in 2019
Portfolio highlights
- WrxFlo — WrxFlo deliver real time data insights and software solutions to allow business achieve greater levels of supply chain efficiencies
- Trustap — Learn how we make buying & selling online safe & secure, every time. Create an account for free today!
- Neurobell — NeuroBell develop novel EEG medical devices for early detection and monitoring of neonatal seizures.
The Yield Lab Europe is a €55m early stage Agrifood and Ag Tech fund which comprises an accelerator and a larger follow-on fund, investing in high tech companies with the potential to significant disrupt and improve our current systems of global food production, and to improve the environmental sustainability of the industry. The main fund invests€1m each into 10-12 companies over several follow on rounds, with the strongest accelerator companies expected to progress to the main fund. The Yield Lab Europe is also part of a global network of Agrifood Tech funds, with global headquarters in St Louis USA, and sister funds in LATAM and Singapore.
Show more...Investment focus
- Industry: AgTech, Agriculture, Biotechnology
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Ireland, France, United Kingdom
Investor stats
- Total investments: 39
- Round size: Seed $1M–$2.9M; Series A $2.1M–$10M; Venture - Series Unknown $1.7M–$9.6M
- Lead/follow: 36% lead, 64% follow
- Last fund: May invest from a new fund soon — raised $52M in 2021
Portfolio highlights
- BBLeap — Farming On Plant Level - We are BBLeap and we are going to create a LEAP in Agriculture! Enabling you to spray exactly what you want. No more, no less!
- BiOceanOr — BiOceanOr harnessed the power of Marine Biology and AI to deliver bio-guided services that optimize fish welfare and fish growth, while supporting aquaculture sustainability standards
- Marama Labs — Marama Labs is a developer of a novel UV-Vis spectroscopy technology for scientific-analytical instrumentation. It assists customers in identifying and measuring turbid samples' characteristics by using light's spectral properties. It offers an ultra-violet and visible spectrophotometer for measuring absorption, extinction, and scatteringspectra of clear and turbid liquids to help customers keep their samples intact, reduce sample preparation steps, and improve measurement turnaround time.
Technology-focused, investing capital and expertise to fuel growth in the most promising ideas and companies. Raised c.€600m across multiple funds and invest from seed to growth.We look for companies with potentially cutting-edge, category-defining businesses in markets including application software, IT infrastructure, communications, Internetand mobile. We help founders create and scale businesses globally. We work as a small team with diverse strengths accessing a community of over 200 founders. The teams and companies we back scale their investor base as they scale their business execution and ambition. We work closely with them in this process. Over the past 25 years have built a broad network of US and European investors and founders that share our vision and approach.Act is based in Dublin, Ireland.Our most recent funds are supported by the European Investment Fund.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Series A
- Geography: Ireland, United States, United Kingdom
Investor stats
- Total investments: 160
- Round size: Seed $823k–$5M; Series A $2.3M–$13M
- Lead/follow: 45% lead, 55% follow
- Last fund: Likely still investing — raised $164M in 2022
Portfolio highlights
- SiriusXT — SiriusXT is transforming cell and tissue imaging with the SXT-100, the first commercial, laboratory scale soft x-ray microscope.
- Fresco — Fresco powers connected cooking experiences for appliance brands, enabling faster launches, lower R&D costs, and continuous innovation.
- Engage-EHS — EcoOnline's easy-to-use software system is helping companies to transform their approach to health & safety, chemical safety & learning data reporting.
We invest in highly technical startups from idea-stage up to Series A.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, Ireland, United Kingdom
Investor stats
- Total investments: 14
- Round size: Seed $3.2M–$5M; Pre-Seed $400k–$400k; Series A $2.5M–$21M
- Lead/follow: 29% lead, 71% follow
Portfolio highlights
- Olio Labs — Olio Labs utilizes AI for combo therapeutics, optimizing and minimizing side effects through automated discovery of protein interactions.
- Current Surgical — Surgery Reinvented - Current Surgical targets early-stage solid tumors in areas where traditional surgical techniques fail.
- Luminate — Luminate Medical is developing LILY, the world's first pain-free and portable solution to prevent hair loss caused by chemotherapy.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Providing capital plus strategic, clinical, operational, financial, and commercial support to deliver the added value inventors seek.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Life Science
- Stage:Series A, Series B, Post-IPO Equity
- Geography: Belgium, Ireland, United States
Investor stats
- Total investments: 5
- Round size: Series A $39M–$39M
- Lead/follow: 60% lead, 40% follow
Portfolio highlights
- Aerska — Aerska develops targeted RNA medicines to treat brain diseases. By silencing genes that cause harm, we can preserve the minds and memories of those we love.
- QurAlis — QurAlis is a operator of a biotechnology company intended to discover and develop potential precision therapeutics for amyotrophic lateral sclerosis (ALS). The company focuses on the link between genetics and disease in ALS and other neurological diseases, enabling doctors to successfully treat ALS .
- New Amsterdam Pharma — We're advancing a new era of treatment for cardiovascular disease and other lipid-related conditions.
We are a Venture & Innovation Platform Advancing the Food & Agriculture Industries We work with leading corporations, startups, universities, and growers to solve the biggest challenges facing the food and agriculture industries.
Show more...Investment focus
- Industry: AgTech, Agriculture, Farming
- Stage:Non-Equity Assistance, Seed, Pre-Seed
- Geography: Canada, United States, Australia
Investor stats
- Total investments: 288
- Round size: Seed $100k–$4.7M; Pre-Seed $50k–$100k
- Lead/follow: 67% lead, 33% follow
Portfolio highlights
- Plasmaleap — Plasmaleap is a plasma technology company that manufactures and sells zero-emissions chemical reactors designed for industrial and energy applications. The company develops reactor systems that use plasma processes to enable chemical production and transformation without relying on conventional combustion methods. Its technology supports sectorssuch as clean fuels, chemical manufacturing, and materials processing by offering electrified reactor solutions that can be integrated into existing industrial workflows. Plasmaleap designs modular systems that allow operators to deploy plasma reactors for on-site production and conversion of feedstocks using electricity as the primary energy input. The company also provides engineering support and technical integration services to help customers incorporate its reactor technology into commercial operations. Through its plasma-based approach, Plasmaleap focuses on enabling chemical processes that align with decarbonization and emissions reduction objectives across multiple industries.
- Cellar Insights — Maximize the value of your potato crop with smart remote monitoring. Monitor storage conditions and prevent crop loss with Cellar Insights.
- Brilliant Harvest — Brilliant Harvest is the Most Powerful AI Helpdesk For Equipment Dealers.
Discover start-up investing made simple. Access VC-led rounds, build your portfolio, and unlock growth at Ascentifi
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Ireland
Investor stats
- Total investments: 9
- Round size: Seed $2.3M–$11M; Series A $9.2M–$34M; Venture - Series Unknown $3M–$3.5M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- CroíValve — CroíValve is a developed a safe, effective, easy to use, percutaneous solution for treating all patients with severe Tricuspid Regurgitation
- Vertigenius — Enhance patient care and treatment options for vertigo and dizziness with Vertigenius, enabling effective management and improved outcomes for your patients.
- X-BOLT Orthapaedics — X-Bolt Trauma Solutions for osteoporotic bone fixation. FDA 510(k) approved. Clinical studies include the WHITE One (n=100) and WHITE Four (n=1,140) randomized control trials.
Artis Ventures has spent over a decade backing bold teams who take the hard path, building market-defining companies to re-shape, re-invent, and re-make industries.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Series A, Series B, Seed
- Geography: United States, United Kingdom, India
Investor stats
- Total investments: 145
- Round size: Seed $2M–$47M; Series A $5M–$57M; Series B $20M–$127M
- Lead/follow: 38% lead, 62% follow
Portfolio highlights
- Ozlo Sleep — Ozlo Sleep is a science-driven sleep and audio technology company that supports and simplifies sleep rituals for clinical benefits, without the use of medication.
- Arkenstone Defense — Arkenstone Defense provides an operating infrastructure platform that integrates government contracting and regulatory compliance into a centralized system for commercial technology companies. The platform manages complex defense requirements, including cleared workforce payroll, personnel security, audit readiness, and technical accreditationframeworks like CMMC and FedRAMP. By embedding these back-office operational controls directly into client environments, the company eliminates the administrative barriers that prevent commercial innovators from selling to the federal market.
- Stateless Networks — Performance, Visibility. Simplicity...It's time for a beautiful network. Stateless is transforming network operations for software-centric networking. Tying together deep network understanding with state-of-the-art distributed systems, cloud, data science and gaming expertise, Stateless transforms network visibility, performance andresponse and helps accelerate the transition to modern network platforms, tying together physical and virtual layers. Focused on the enterprise data center, Stateless currently partners with the world’s leading network and infrastructure vendors (including VMware (VMW), Cisco Systems (CSCO), Cumulus Networks and others) to deliver solutions to some of the world’s largest private data center operators. We’re looking for software and networking engineers in Greater Seattle and the Bay Area with expertise in one or more of the following areas: Distributed Systems, Service Oriented Architecture, Complex Event processing, Functional Programming, Virtualization, Network design and deployment, Network programming, Network troubleshooting, configuration and performance tuning and SDN. Bonus points for experience working with cloud infrastructure (AWS, Azure, OpenStack) or low-level systems software (linux kernel, hypervisors, compilers/language runtimes), complex gaming systems or graphics and computational geometry. For more information visit http://www.statelessnetworks.com/ or follow Stateless on Twitter: @statelessntwrks.see
Enterprise Equity (or EEVC) is an excellent for providing capital to early stage and expanding business throughout Ireland.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Series B
- Geography: Ireland, United States, United Kingdom
Investor stats
- Total investments: 51
- Round size: Seed $549k–$2.2M; Series B $2.6M–$7.5M
- Lead/follow: 10% lead, 90% follow
Portfolio highlights
- Phorest — Join 8000+ spas, barbers, hair, beauty and nail salon owners using the #1 management, scheduling, POS and appointment booking system. Try Phorest now!
- SurgaColl — SurgaColl Technologies is a medical device company developing novel tissue regeneration products for the surgical treatment of diseases of the bone, cartilage and other human tissue. Based on technology developed at the Tissue Engineering Research Group (TERG) of the Royal College of Surgeons in Ireland (RCSI), headed by Professor Fergal O’Brien,the company aims to become a leader in the field of regenerative medical devices.
- Metabolomic Diagnostics — Metabolomic Diagnostics is a deep-tech company specialized in the development of novel biomarker based diagnostic solutions for complex diseases. The company has developed an effective pipeline to firstly identify diagnostic biomarker panels and then translate these panels into clinical assays ready for application in the clinical laboratory.Thispipeline combines the biomarker multiplexing capabilities of Mass Spectrometry, a powerful analytical technology, with the company’s own informatics and statistics solutions to deliver diagnostic innovation. This is reflected in Metabolomic Diagnostics’ strong and versatile IP portfolio of technical innovations and biomarkers.Our VisionMetabolomic Diagnostics’ primary vision is to develop a portfolio of diagnostic solutions which can determine, early in a woman’s pregnancy,her risk of developing major complications much later in her pregnancy and thus enabling personalized care, adapted to each woman’s individual needs. Pregnancy complications like preeclampsia, gestational diabetes, preterm birth, and in-uterine growth restriction, all have the potential to severely impact on the well-being of mother and child.The company’s innovative diagnostic solutions will assist clinicians in re-imagining how these conditions are managed: our novel risk assessment tools are specifically developed in conjunction with prenatal care providers to ensure they make a difference that really matters. This in turn will enable clinicians to improve pregnancy outcomes globally.Our solutions will empower pregnant women: accurate pregnancy risk information will allow a pregnant woman, in partnership with her care provider, to determine what prenatal care is best for her pregnancy.
Infinity Capital are hypothesis-driven investors - constantly calibrating ideas through a Silicon Valley/technology network that they've been building for over two decades. Their extensive technology and operating backgrounds, combined with over a dozen years each of successful startup investing, have been essential in buildingcredibility and a reputation that resonates with entrepreneurs.
Show more...Investment focus
- Industry: Semiconductor, E-Commerce, Electronics
- Stage:Series B, Series D
- Geography: United States, Ireland, Canada
Investor stats
- Total investments: 33
- Lead/follow: no public data
Portfolio highlights
- AltraTech — Next Generation Molecular Detection Discover Altratech Next Generation Molecular Detection Discover Altratech At Altratech, our mission is to enable next generation molecular detection.
- BioSapien — BioSapien is a pre-clinical biotech company developing novel biodegradable implantable products that deliver active pharmaceutical ingredients (APIs) for oncology indications with reduced systemic side effects. The applications for this technology are currently under investigation for pancreatic cancer and lung cancer. The intended pipeline ofindications is expected to expand into other cancers such as colorectal, breast, and stomach cancers. BioSapien's 3D-printed MediChip delivers FDA-approved toxic high-dose systemic therapies in a localized slow-release biodegradable mesh which is able to target tissues while improving patients' quality of care and life.
- Core Starters — Core Starters services startups and investors through blockchain-based decentralized services to solve real problems.
DeepIE Ventures Management Co. operates as a venture capital firm.
Show more...Investment focus
- Industry: Manufacturing, AgTech, Software
- Stage:Seed, Series A
- Geography: Ireland, France, Switzerland
Investor stats
- Total investments: 11
- Round size: Seed $648k–$5.5M
- Lead/follow: 9% lead, 91% follow
Portfolio highlights
- eID easy — One integration - access a worldwide network of QTSPs & CAs, for eSignatures, eID authentication & eSealing. Ensure full compliance with regulations.
- ArrayPatch — Revolutionising drug delivery with painless microneedle patch technology. Backed by prestigious funding and award-winning innovation.
- Marama Labs — Marama Labs is a developer of a novel UV-Vis spectroscopy technology for scientific-analytical instrumentation. It assists customers in identifying and measuring turbid samples' characteristics by using light's spectral properties. It offers an ultra-violet and visible spectrophotometer for measuring absorption, extinction, and scatteringspectra of clear and turbid liquids to help customers keep their samples intact, reduce sample preparation steps, and improve measurement turnaround time.
Building world-changing companies in sunny Miami
Show more...Investment focus
- Industry: Software, Artificial Intelligence, FinTech
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, France, United Kingdom
Investor stats
- Total investments: 516
- Round size: Seed $880k–$7.3M; Pre-Seed $125k–$3.5M; Series A $5.5M–$35M
- Lead/follow: 3% lead, 97% follow
Portfolio highlights
- Brekfuz — Brekfuz is an AI startup that builds an intelligent coordination platform called The Human API. The system transforms undocumented human knowledge and digital exhaust into structured endpoints to eliminate information bottlenecks. This allows both human teammates and autonomous AI agents to query institutional memory directly without waiting forhuman availability
- Omen AI — Harness the power of Ai and proprietary sensing to prevent equipment failures.
- PAVE Space — PAVE Space develops in-space transportation and satellite servicing technologies that enable movement and management of payloads across different orbits. The company builds spacecraft systems centered around a kickstage platform that transfers multi-ton payloads from low Earth orbit to target orbits within short timeframes using onboard propulsionsystems. Its core offering focuses on orbital mobility, providing services that bridge the gap between launch vehicles and final satellite deployment by repositioning payloads after initial launch. The platform is designed to integrate with multiple launch providers and supports both rideshare and dedicated missions through compatible interfaces and propulsion technologies.Beyond transportation, PAVE Space develops capabilities for in-orbit operations, including satellite inspection, life extension, docking, and servicing. These functions use a combination of propulsion systems, guidance and control algorithms, and autonomous technologies to manage spacecraft activities and extend satellite usability.
Gaingels is a venture investment syndicate in service of the LGBT+ community and its allies, investing in companies with LGBT+ founders and C-suite leaders at all stages of growth, as well as in more established companies resolved on building more inclusive teams, with a global portfolio of 130+ companies and $70M in deployed investment capital todate. The Gaingels network also actively supports its portfolio in identifying and recruiting diverse talent to their C-suite and board leadership teams and fosters a vibrant global community of industry leaders, investors, operators, and entrepreneurs who share a common goal for positive social change through business and successful investments.
Show more...Investment focus
- Industry: Software, Health Care, Artificial Intelligence
- Stage:Seed, Series A, Series B
- Geography: United States, Canada, Mexico
Investor stats
- Total investments: 1258
- Round size: Seed $1M–$8.5M; Series A $5.5M–$37M; Series B $16M–$100M
- Lead/follow: 1% lead, 99% follow
- Last fund: Likely actively investing — fund raised in 2024
Portfolio highlights
- Quadient Accounts Receivable by YayPay — YayPay accounts receivable automation software helps businesses collect faster, forecast cash flow accurately, and improve payment process. Automate your AR
- Sharper Sense — Neuromodulation for Clear Senses
- Willow Wealth — Willow Wealth is an alternative investment platform focused on generating income streams for investors. Get exclusive access to private market investments.
Lynett Capital is an early stage investment firm dedicated to the empowering technology companies.
Show more...Investment focus
- Industry: FinTech, Software, SaaS
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, Kenya, Nigeria
Investor stats
- Total investments: 29
- Round size: Seed $120k–$3M; Pre-Seed $500k–$2.7M; Series A $2.5M–$49M
- Lead/follow: 0% lead, 100% follow
- Last fund: May invest from a new fund soon — last raise in 2018
Portfolio highlights
- Juxta — Juxta delivers infrastructure-free positioning for people, assets, and robots. Track indoors, outdoors, and GPS-denied environments with the Universal Positioning System, Software SDK, and Asset Tags.
- Ribbon — Go live with an inheritance center that your members deserve
- Luminate — Luminate Medical is developing LILY, the world's first pain-free and portable solution to prevent hair loss caused by chemotherapy.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Lightstone Ventures is a global venture capital firm that invests in personalized medicines and targeted therapeutics. Lightstone Ventures was founded in 2012 by the General Partners and other key members of the life science teams of Advanced Technology Ventures (ATV) and Morgenthaler. The firm was formed to capture the upside of investing inbreakthrough life science companies during a time of unique opportunity in space.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Series C
- Geography: United States, Ireland, India
Investor stats
- Total investments: 85
- Round size: Series A $7M–$95M; Series B $18M–$100M; Series C $20M–$105M
- Lead/follow: 26% lead, 74% follow
- Last fund: Likely still investing — raised $375M in 2021
Portfolio highlights
- Cerevance — Cerevance is a developer of novel therapeutics intended to advance new medicines for serious neurological diseases.The company's therapeutics applies it's technology called NETSseq to reveal transcriptional and epigenetic differences between specific cell types in mature human brains, enabling healthcare providers to detect and tackle theearly onset of various neurological diseases.
- Psivant Therapeutics — PsiThera is advancing programs across multiple targets from the TNF superfamily and beyond, where no oral therapies currently exist.
- Crystalys Therapeutics — Transforming care for people living with gout.
HealthCap, a life science investor and company creator. Our motivation is to find innovative ideas and invest that could impact healthcare and society.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Series A
- Geography: United States, Sweden, France
Investor stats
- Total investments: 133
- Round size: Series A $5.7M–$85M; Series B $12M–$92M
- Lead/follow: 24% lead, 76% follow
- Last fund: May invest from a new fund soon — raised $209M in 2019
Portfolio highlights
- Neobiomics — Neobiomics is a Swedish life-science company that develops nutritional products for preterm infants and neonatal care. Its best-known products include ProPrems® and NeoMega36®.
- CurifyLabs — CurifyLabs enables 3D printed personalized medicines in pharmacies and hospitals. Always close to the patient.
- Ultragenyx Pharmaceutical — Ultragenyx is focused on developing first-ever approved treatments for rare and ultrarare diseases and moving the rare disease community forward.
ARCH Venture Partners provides seed / early stage venture capital for technology firms in information technology, life sciences, and physical sciences
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Series C
- Geography: United States, China, United Kingdom
Investor stats
- Total investments: 433
- Round size: Series A $10M–$216M; Series B $14M–$250M; Series C $15M–$167M
- Lead/follow: 31% lead, 69% follow
- Last fund: Likely actively investing — fund raised in 2024
Portfolio highlights
- Synchron — The endovascular brain computer interface.
- Parabilis Medicines — Parabilis Medicines is a biopharmaceutical company in the clinical stage that focuses on developing exceptional medications targeting challenging protein structures previously deemed undruggable. Utilizing more than ten years of exclusive data, innovative laboratory techniques, and algorithms based on AI and physics, the company has introduced anovel category of stabilized, cell-penetrating alpha-helical peptides known as Helicons™. These peptides can modulate intracellular proteins that traditional drug modalities cannot reach.
- LifeMine Therapeutics — LifeMine is a clinical-stage biopharmaceutical company pioneering a bold new approach, Top-Down Drug DiscoveryTM, which leverages evolutionary insights from fungi to unearth next-generation precision medicines.
Tuned for performance. SOL Global Investments is a diversified private equity firm targeting best-in-class companies that operate in ultra-high growth industries. Our team has a proven track record of identifying pioneering businesses that are poised to disrupt the status quo and take
Show more...Investment focus
- Industry: Health Care, Cannabis, Cloud Computing
- Stage:Corporate Round, Series A, Series B
- Geography: United States, Canada, Ireland
Investor stats
- Total investments: 11
- Lead/follow: no public data
Portfolio highlights
- Semasio — The Fyllo Compliance Cloud is a suite of software and services that enable organizations to navigate today’s ever-changing regulatory landscape, streamline compliance, and scale with speed. Mainstream brands also use the Fyllo Data Marketplace to target previously inaccessible cannabis and CBD consumers.The company was founded in 2019 and isheadquartered in Chicago, Illinois.
- Cityrow Go — Cityrow Go is a rowing-based fitness app for smartphones or tablets. It offers rowing classes programmed to deliver an effective, efficient, and motivating workout to the at-home user. It was founded in 2013 and is based in New York, United States.
- MCQ Markets — Start Investing in Investment-Grade Collector Cars with just $100. MCQ gives you access to invest in the same high-performance assets collectors and institutions are competing for.
Medicxi is an investment firm that focuses on the life sciences sector. It was established in 2016 by the former Index Ventures life sciences team, who have been active for over 20 years and have significant experience in drug discovery and the development of therapeutics for unmet medical needs.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Series A, Series B, Seed
- Geography: United States, United Kingdom, The Netherlands
Investor stats
- Total investments: 53
- Lead/follow: no public data
Portfolio highlights
- Curevo — focused on a new generation of adjuvanted subunit vaccines Learn More Our Focus We're dedicated to developing non-mRNA vaccines for unmet medical needs Curevo Vaccine is a clinical-stage biotech company dedicated to developing next-generation non-mRNA vaccines. We focus on one need at a time, allowing us to bring effective and better-tolerated vaccines to market quickly
- D3 Bio — D3 Bio is a globally focused biotechnology company focusing on developing and registration of innovative medicines in oncology and immunology. At D3 Bio, our new medicine development approach is fundamentally differentiated. We do not just only start with science in the lab. First, we pinpoint the greatest unmet patient and market needs – whereexisting standard-of-care approaches yield unsatisfactory clinical outcomes. Then we take those insights into the lab to guide the identification of fit for purpose science and technology and define our drug development path.
- Palladio Biosciences — Palladio Bio is a clinical-stage company developing transformative medicines for orphan diseases of the kidney. The company specializes in the fields of biotechnology, pharmaceutical. and therapeutics. Its products are designed for renal disease, kidney disease, and polycystic kidney disease.The company was founded in 2015 and headquartered inHorsham, Pennsylvania.
Inventages Venture Capital Investment Inc is an investment arm of Nestle SA specializing in PIPES, seed, early, mid, and late venture investments. The firm seeks to invest in middle market and mature companies. It provides mezzanine and bridge financing. The firm seeks to invest in health care, life sciences, cosmeceuticals, pharmaceuticals,enabling technologies and services, and diagnostic and medical devices. Within the pharmaceutical sector, it typically invests in small molecules, proteins, antibodies, vaccines, phytopharmaceuticals, natural compounds, botanicals, antibiotics, and therapeutics. Within the diagnostic sector, it focuses on genetic materials, biomarkers, pathological markers, genetic profiles, protein profiles, pharmacogenomics, food and environmental safety, genetically modified organism detection and trading, medical monitoring, diagnostic and analytical tools, and quality control. Within enabling technologies and services it primarily invests in novel packaging, process and production technologies, supply chain management, innovative materials and resources, delivery systems for active compounds, encapsulation and prevention, food services, extraction and fractionation of biological materials, consumer relation management, green biotechnology, smell and taste modifying technologies, genomics, proteomics, metabolomics, screen and characterization technologies, chemical and biological engineering, and innovative preventive and therapeutic concepts. It also invests in companies involved in the prevention of medical foods, nutraceuticals, cosmoceuticals, nutrition, innovative food, functional food, dietary and food supplements, oral and skin care, immune modulation and stimulation, and health and disease management.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B
- Geography: United States, United Kingdom, Canada
Investor stats
- Total investments: 37
- Lead/follow: no public data
Portfolio highlights
- Accera — Accera is a biotechnology company that engages in the discovery and development of therapeutic drugs for neurodegenerative diseases. It offers Ketasyn, a molecule for Alzheimer's, Parkinson's, and age-associated memory impairment. It was founded in 2001 and is headquartered in Broomfield, Colorado.
- XOLUTION — XOLUTION is the most advanced reclosable beverage container solution. Already in its prototype state, the new XO resealable can won the Can of the Year Award in Dubai in 2009 (Winner Silver - Category Prototype) and was enhanced and refined since, involving extensive market research and field testing. With the can now entering the consumer beveragemarket, they are confident that the product resembles a step forward for XOLUTION in becoming the market leader in this field. XOLUTION GmbH is headquartered in Munich, Germany. In 2008, Marc von Rettberg was named Chief Executive of the company. He joined Christian Bratsch, Vice President R&D, to introduce innovative designs to the beverage packaging industry for reclosable beverage cans.Rettberg and Bratsch established new product design guidelines with a clear focus on values and benefits for the entire supply chain. The innovative beverage can ends were required to offer easy usage to the consumer (intuitive, easy to open and reseal), easy integration for the beverage filler in the existing processes (no major adjustments to the filling line), easy handling for the can maker (XO reclosable can ends based on standard shells), and improved commercialization for the beverage brand (unique branding options). And, of course, the focus was set on providing these benefits at a reasonable overall cost.In 2009, Can Maker Magazine recognized the XOLUTION innovative resealable can with the Silver Award in the Prototype category for the XO-400 reclosable beverage can lid. Since Time-to-Market is a key challenge for all innovators, Rettberg and Bratsch have created a competitive advantage of rapid prototyping and testing capabilities in their Salzburg R&D Center. XOLUTION GmbH is managed by one of the most competent teams in the business. With long-term experiences in their respective fields, their leading specialists guarantee the best coverage of all business areas from prototyping, R&D and product management to trading and distribution. With their knowledge, the XO Resealable Can was successfully converted from a simple vision to a technologically sophisticated product that will have a significant influence on the canned beverage market.
- Ripple Foods — Ripple Foods offers a nutritious & delicious milk alternative that is 100% dairy-free, vegan, nut-, lactose- & gluten-free. Discover more about Ripple milk!
MML Capital Partners is an independent investment firm, with over twenty years of history, focused on providing capital to businesses for expansion/acquisitions, management-led equity deals, recapitalisations and buy-outs.
Show more...Investment focus
- Industry: Manufacturing, Packaging Services, Information Technology
- Stage:Private Equity, Series A
- Geography: United Kingdom, France, United States
Investor stats
- Total investments: 30
- Lead/follow: no public data
Portfolio highlights
- RAVL — Step into the future with RAVL and our revolutionary financial service technology solutions. We're not just building tech; we're crafting the future of financial services. Unleashing potential, one innovative solution at a time. Let's strategize, deliver, and repeat excellence together.
- SCPACK GROUP — SCPACK GROUP is a packaging and containers manufacturing company for wine, cosmetics and more.
- Ross-shire Engineering — Trusted water technology solutions and products for purifying drinking water, recycling effluent and cleaning water in industrial processes.
GV supports innovative founders moving the world forward.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Series A, Series B, Seed
- Geography: United States, United Kingdom, Switzerland
Investor stats
- Total investments: 902
- Lead/follow: no public data
Portfolio highlights
- Instawork — Instawork connects local businesses with proven hourly workers for temp, temp-to-hire shift work.
- SingleStore — SingleStore is a provider of a database for operational analytics and cloud-native applications. It provides global enterprises with an intelligent database that works on any cloud on-premises or as a service runs transactions and analytics at the same time and lets clients promote their business through analytics and combine semi-structured datainto a consolidated big data platform.
- Resistant AI — Resistant AI provides fraud detection and prevention in automated document processing workflows, transaction monitoring, and identities analysis.
KBI Biopharma Inc. is a global contract development and manufacturing organization (CDMO / CMO) offering Cell Line Development, Process Analytical & Formulation Development, Clinical & Commercial Manufacturing, and more.
Show more...Investment focus
- Industry: Biotechnology, Life Science, Medical
- Stage:Seed, Series A, Series D
- Geography: United States, Ireland
Investor stats
- Total investments: 3
- Lead/follow: no public data
Portfolio highlights
- Absci — A better, faster path to new medicines. We translate ideas into drugs with an AI-powered approach to biologic drug discovery and cell line development.
- GlycoSeLect — GlycoSeLect Ltd specialises in the development and production of Recombinant Prokaryotic Lectins (RPLs).
- Comera Life Sciences — ReForm Biologics is an engineering superior biotherapeutic formulation for fragile patients. Its proprietary technology provides patented, FDA-friendly excipients for a wide range of therapeutic biologics. Using its platforms, drug companies can make life-saving medicines easier to administer, less immunogenic, more stable, and more efficient toproduce. It was founded in 2014 and is based in Woburn, Massachusetts.
Sanara MedTech is in the business of improving patient outcomes through advanced healing solutions and biotechnology. Call us at 817-529-2300!
Show more...Investment focus
- Industry: Medical, Biotechnology, Medical Device
- Stage:Corporate Round
- Geography: Ireland
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Biomimetic Innovations — Biomimetic Innovations is a medical device company that specializes in the development and commercialisation of synthetic biomaterial technology for tissue repair.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Founded in 1997, Earlybird invests in all development and growth phases of technology companies. Among the most experienced venture investors in Europe, Earlybird offers its portfolio companies not only financial resources but also strategic support plus access to an international network and capital markets. With EUR 2 billion under management,eight IPOs and 30 trade sales, Earlybird is one of the most established and active venture capital firms in Europe.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Series A, Seed, Series B
- Geography: Germany, United States, United Kingdom
Investor stats
- Total investments: 305
- Lead/follow: no public data
Portfolio highlights
- TopK — TopK features native support for both vector search and keyword search in a single, unified system. With its powerful query expression language, TopK enables you to build reliable search applications (semantic search, RAG, multi-modal, you name it) without juggling multiple databases or services. Our unified retrieval engine will evolve tosupport document transformation, query understanding (parse metadata filters from user query), and adaptive ranking (provide more relevant results by sending “relevance feedback” back to TopK) under one roof.
- Arago — Arago is an AI and computer hardware company developing an energy-efficient AI chip powered by light, and its associated software.
- Portal Biotech — Portal has created next generation solutions that address the significant opportunities in protein sequencing and metabolomics
Carragh Holdings
Show more...Investment focus
- Industry: Biotechnology, Bioinformatics
- Stage:Series A
- Geography: Ireland
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Kastus Technologies — Kastus is embedded into glass during manufacturing. Creating the world's first surface that constantly cleans itself of over 99% of germs and viruses, including Covid 19. It works 24/7, for the lifetime of the glass.
Investing globally in Frontier & Consumer businesses at pre-seed or seed.
Show more...Investment focus
- Industry: Software, SaaS, FinTech
- Stage:Seed, Pre-Seed, Series A
- Geography: United Kingdom, United States, France
Investor stats
- Total investments: 48
- Round size: Seed $849k–$6M; Pre-Seed $550k–$3.5M; Series A $7M–$36M
- Lead/follow: 17% lead, 83% follow
Portfolio highlights
- Ovo Labs — Ovo Labs is developing therapeutics that boost egg quality to enhance IVF success, technology aims to extend the timeline when the chances of conception are high.
- Ignota Labs — Ignota Labs for in silico toxicity prediction.
- Caribou — We set Transfer Pricing policies and intragroup agreements for international businesses
EarlyBirdCapital, Inc. (“EBC”) is a registered broker-dealer1 and member of the Financial Industry Regulatory Authority, Nasdaq Stock Market, Inc., Municipal Securities Rule Making Board, and Securities Insurance Protection Corporation2. EBC is a boutique investment bank that has developed an expertise in working with smaller capitalizationcompanies, special situation investments and Special Purpose Acquisition Companies (SPACs:tm:), a new concept they pioneered and developed that involves publicly-traded, industry-specific acquisition funds.
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Stage:Seed
- Geography: Ireland
Investor stats
- Total investments: 1
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- Perfuze — Perfuze was founded in 2018 by Wayne Allen and Liam Mullins. Perfuze is located within Galway City in the West of Ireland. The founders have over 30 years combined medtech experience within start-up and large corporations.Perfuze is developing innovative medical technology to treat acute ischemic stroke.Perfuze is developing innovative cathetertechnology to treat acute ischemic stroke. Their technology is intended to provide superior clinical outcomes in shorter procedural times; resulting in safe, cost-effective therapy. Perfuze was founded in 2018 by Wayne Allen and Liam Mullins. The founders have over 30 years combined medtech experience within start-up and large corporations. Perfuze is currently located in the Business Innovation Centre on the campus of the National University of Ireland, Galway, and is in the process of relocating to the IDA Business Park in Dangan, Galway.
Ascent Capital is a leading India-focused independent private equity firm. They are one of the most experienced teams on ground with over 150+ years of collective experience in Indian capital markets. Over the past 15 years they have helped over 55 entrepreneurial teams build leading businesses across diverse sectors such as Technology, Ecommerce,Healthcare, Financial Services, Consumer Brands, Infrastructure, etc.
Show more...Investment focus
- Industry: Financial Services, Banking, Health Care
- Stage:Series C, Series B
- Geography: India, United States, Ireland
Investor stats
- Total investments: 41
- Round size: Series B $12M–$33M; Series C $2.5M–$50M
- Lead/follow: 49% lead, 51% follow
Portfolio highlights
- EnKash — Enkash is now Asia's 1st and Smartest Spend Management Platform that offer services like Account Payable, Accounts Receivable, Expense Management & many more.
- Freshtohome — Freshtohome is an online grocery store that sells a range of seafood and meat to its users.The website’s range of products include fish, poultry, mutton, steaks, and fillet. Fish consists of shell, freshwater, and marine. Furthermore, it enables suppliers to supply their seafood and meat to the website.Freshtohome was launched in 2015 by ShanKadavil and is based in Bangalore.
- Orbital — Orbital is a startup that is creating artificial intelligence data centers for deployment in low-Earth orbit to circumvent terrestrial power and cooling limits. The company specializes in satellite-based compute for AI inference workloads, utilizing continuous solar power and space's inherent radiative cooling.
Covidien plc engages in the development, manufacture, and sale of healthcare products for use in clinical and home settings. Segments The company operates its businesses through four segments: Medical Devices includes the development, manufacture and sale of endomechanical instruments, soft tissue repair products, energy devices, oximetry andmonitoring products, airway and ventilation products, vascular devices, SharpSafety products, clinical care products and other medical device products; Imaging Solutions includes the development, manufacture and marketing of radiopharmaceuticals and contrast products; Pharmaceutical Products includes the development, manufacture and distribution of dosage pharmaceuticals and active pharmaceutical ingredients; and Medical Supplies includes the development, manufacture and sale of nursing care products, medical surgical products and original equipment manufacturer products (OEM). The Medical Device segment develops, manufactures and sells an array of products which the company categorizes in the following product groups: - Endomechanical Instrumentsâ includes its laparoscopic instruments and surgical staplers. - Soft Tissue Repair Productsâ includes its sutures, mesh and biosurgery products. - Energy Devicesâ includes its vessel sealing, electrosurgical and ablation products and related capital equipment. Oximetry and Monitoring Productsâ includes its sensors, monitors and temperature management products. Airway and Ventilation Products—includes its airway, ventilator, breathing systems, sleep and inhalation therapy products. Vascular Devicesâ ”includes its compression and vascular therapy products. SharpSafety Productsâ includes its needles, syringes and sharps disposable products. Clinical Care Productsâ includes its urology, enteral feeding and other advanced woundcare products.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Series A, Series C
- Geography: Ireland, United States
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- FIRE1 — FIRE1 and is based in Dublin, Ireland, will focus on developing novel therapeutic devices.
- AEGEA Medical — CooperSurgical: Advancing women's health & fertility solutions. Empowering clinics with innovative tech for better patient outcomes.
Street Capital Financial Corporation is a Canadian wholesale lending company. As a wholesale lender, Street Capital doesn’t have an expensive branch network and as such can pass those savings to the consumer. Street Capital prides itself on offering consumers competitive products and interest rates with an exceptional level of service.Havingapproved lender status with Canada Mortgage and Housing Corporation (CMHC) Street Capital is able to offer a broad spectrum of residential mortgage financing products to the consumer. Also, since we’re primarily focused on the mortgage broker origination channel, you’re assured that your mortgage will fit your needs comfortably.By continually working to develop innovative lending solutions and working in partnership with your local mortgage brokers, Street Capital is proud to help more Canadians realize their dreams of home ownership and enhancement.
Show more...Investment focus
- Industry: Medical, Automotive, Biotechnology
- Stage:Seed
- Geography: Ireland, United States
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Biosensia — Biosensia is a Point-of-Care in-vitro diagnostics company that has a novel point-of-care platform, RapiPlex, available for licensing. RapiPlex combines highly innovative technologies to produce a practical, rapid, multiplexing POC in-vitro diagnostics (IVD) platform, enabling access to a broad range of diagnostic applications. Its componentchip and cartridge system are compatible with a variety of common biological sample types, including whole blood, serum, saliva, urine and nasal/genital swabs.
- Drive Time Metrics — Drive Time Metrics is developing innovative new revenue streams from connected car data, and helping automotive OEMs monetize their connected vehicle platforms.
Wellcome Trust is a medical research charity that funds research that aims to protect and improving human and animal health. It focuses on the fields of public engagement, investments, innovation, humanities, and social science. It was founded in 1936 and headquartered in London, England.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Grant, Series C
- Geography: United States, United Kingdom, France
Investor stats
- Total investments: 121
- Round size: Grant $1.3M–$8.9M; Series C $10M–$127M
- Lead/follow: 39% lead, 61% follow
- Last fund: May invest from a new fund soon — raised $319M in 2018
Portfolio highlights
- System — System is a free, open, and living public resource that aims to explain how anything in the world is connected to everything else.
- Lario Therapeutics — Lario Therapeutics is a biopharmaceutical firm that develops precision therapeutics for epilepsy and neurological disorders.
- Ineffable Intelligence — Ineffable Intelligence develops machine learning systems that learn through interaction and experience. The company works on reinforcement learning approaches that allow models to improve by trial and error rather than relying on large human-generated datasets. Its core work centers on building a “superlearner,” a system designed to generateknowledge and skills by engaging with simulated or real environments.The organization develops algorithms and computational frameworks that support autonomous learning, experimentation, and decision-making processes. Its efforts involve designing AI models that can adapt, refine behavior, and solve complex problems through continuous feedback loops. The company’s research aims to expand how AI systems acquire knowledge and apply it across different domains.
Cultivian Sandbox is a venture capital firm focused on building next-generation disruptive agriculture and food technology companies capable of generating superior returns. As early investors and active board members, we employ a hands-on approach to building companies and are often directly involved in setting company strategy, recruiting keyexecutives, and raising additional capital. Much more than simply a financial resource, we are capable of delivering tremendous value though active collaboration with our strategic partners and network, which are unparalleled in the agriculture and food industries.As both experienced operating managers and venture investors we add value to portfolio companies both through our highly skilled team and extensive industry network. Our investment team combines the domain expertise and investment experience from Cultivian Ventures and Sandbox Industries. Our expertise in sourcing, evaluating, closing, managing and ultimately exiting successful equity investments positions us not only to build stronger businesses, but reshape industries.
Show more...Investment focus
- Industry: Biotechnology, Agriculture, Farming
- Stage:Series A, Series B, Series C
- Geography: United States, Canada, Germany
Investor stats
- Total investments: 45
- Round size: Series A $2M–$23M; Series B $12M–$80M; Series C $13M–$22M
- Lead/follow: 49% lead, 51% follow
- Last fund: May invest from a new fund soon — raised $135M in 2019
Portfolio highlights
- Debut — Debut Biotech develops biotechnology-based beauty ingredients and formulations in a vertically integrated manner, beginning with AI-powered discovery and continuing through biosynthesis, biomanufacturing, downstream processing, and finished formulations. The company utilizes its BeautyORB platform to computationally screen vast chemical librariesand predict novel bioactives, which then proceed through validation, safety testing, and formulation for skincare and haircare applications. Debut employs both engineered microbial fermentation and cell-free enzymatic systems to produce these novel ingredients sustainably and then transitions them into proprietary formulations or custom white-label products.
- Culture Biosciences — Culture Biosciences provides a platform of cloud-connected bioreactors, software tools, and process development services that support upstream bioprocess development for biotech and biopharma applications. The company’s offerings include remote experiment design, monitoring, and data analysis through an integrated cloud software interface pairedwith single-use bioreactors for microbial fermentation and cell culture experimentation. Its services encompass clone and strain screening, process optimization, characterization, and bioprocess modeling to help scientific teams refine and scale their workflows. Clients access real-time data and analytics to inform decisions and collaborate across teams using the platform’s tools. Culture Biosciences’s technology is used to advance development of therapeutics, synthetic biology products, and related bioprocesses. Culture Biosciences was founded in 2016 and is headquartered in San Francisco, California.
- AbCelex Technologies — SpaceAble is building an on orbit inspector to contribute to a New Space resilience infrastructure based on certified data.
The Foundry, LLC is the premier medical device company incubator. We work with inventors to rapidly transform their concepts into companies by providing an incomparable combination of leadership, an experienced, multi-disciplinary team, a state-of-the-art facility and an extensive funding network. The Foundry Team is comprised of veteran medicaldevice entrepreneurs and investors with real world experience—and success—in developing world class medical device companies.
Show more...Investment focus
- Industry: Health Care, Therapeutics, Biotechnology
- Stage:Series A
- Geography: Ireland
Investor stats
- Total investments: 1
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- FIRE1 — FIRE1 and is based in Dublin, Ireland, will focus on developing novel therapeutic devices.
Biotech VC funding in Ireland at a glance
Stats across 260 deals from 257 investors.
Access all 257 VC funds in Ireland Biotech startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Biotech VC Funds in Ireland investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 257 VC funds investing in Ireland Biotech startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!